The oligonucleotide synthesis market is anticipated to grow at a CAGR of around 12.7% during the forecast period. The growth in the life science industries and rising application in therapeutics, genetics, and genomics in the research and diagnostics.The oligonucleotide synthesis market has been growing significantly owing to increasing online and strong pipelines of the oligonucleotide, the growing burden of chronic diseases and rising consolidation of the market. However, lack of regulatory scenario for the oligonucleotide, challenging drug delivery technique and complex therapeutics classification owing to a large range of oligonucleotides is the restraining factor that hampers the market growth.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/oligonucleotide-synthesis-market
The oligonucleotides services offered by the manufacturers are available based on the customer requirement that enables the identification of specific genes in the procedure of life science research. Different types of fragment oligonucleotides are available that are prepared and used by various industry such as for research for life science, the oligos are utilized as PCR probes and primers, gene editing (CRISPR), and DNA sequencing for the diagnostics applications. The oligonucleotide is used as a microarray panel, therapeutics application and fluorescence in situ hybridization and as well as used as nucleic acid aptamers, antisense, gene, and cell therapy and among others. Moreover, the large range of applications in the area of research, therapeutics, data storage, synthetic biology, increasing research-oriented programs, diagnostics, and drug discovery are fuelling the requirement of the oligonucleotide synthesis in the biotechnology industry.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/oligonucleotide-synthesis-market
Currently, the market has witnessed a considerable increase in the acquisition of various small-scale oligonucleotide synthetic companies by key players to vast their product & services offerings and improve their presence in the market. For instance, in April 2019, GenScript had announced a launch of single-stranded DNA services. The new services provide researchers to access high quality, DNA for CRISPER based gene insertion, cell therapy, enabling to accelerate the development of gene therapy and also the transgenic animal model for cancer treatment. Moreover, across the globe,the oligonucleotide synthesis market is increasing owing to favorable government policies, increasing prevalence of infectious diseases such as hepatitis and cancer, advancements in synthesis technology, and ongoing research in synthetic biology.
Market Segmentation
By Product
Synthesized Oligonucleotide Product
- Probe
- Primer
- Other (Linkers)
Reagent
Equipment
By Type
- Custom
- Pre-Designed
By Application
- Research
- Diagnostics
- Therapeutics
Regional Analysis
North America
- US
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- Agilent Technologies, Inc.
- Ajinomoto Co., Inc.
- ATDBio, Ltd.
- Biolytic Lab Performance Inc.
- Bio-Synthesis Inc.
- Danaher Corp.
- Eurofins Genomics, LLC
- Eurogentec S.A.
- General Electric (GE) CO.
- GenScriptBiotech Corp.
- LGC, Ltd.
- Merck KGaA
- Nitto Denko Avecia Inc.
- PolygenGmbh
- Quintara Biosciences
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
